0.9600USD+4.95%Mkt Cap: 10.86M USDP/E: —Last update: 2026-05-22
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is Car…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap10.86M USD
Enterprise Value9.83M USD
Revenue (TTM)—
Gross Profit-4.96M USD
Net Income (TTM)-8.23M USD
Revenue/Share—
Last Price0.9600 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.63
PEG—
EV/EBITDA-1.26
EV/Revenue—
P/S—
P/B-9.40
EPS (TTM)-0.85
EPS (Forward)-0.56
52W Range
0.84007% of range2.450
52W High2.450 USD
52W Low0.8400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-919.33%
ROA-241.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.44M USD
CapEx (TTM)7.00K USD
FCF Margin—
FCF Yield-44.98%
Net Debt-539.00K USD
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.59
Current Ratio0.41
Quick Ratio0.35
Book Value/Sh-0.0970 USD
Cash/Share0.0840 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 6, 2019
Splits
Last Split1:15
Split DateMay 30, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)15.50 USD
Target Range6.000 USD – 25.00 USD
# Analysts2
Ownership
Shares Out.11.37M
Float8.67M
Insiders30.02%
Institutions7.13%
Short Interest
Short Ratio2.7d
Short % Float1.83%
Short % Out.1.52%
Shares Short165.82K
Short (prev mo.)177.34K
Technical
SMA 501.150 (-16.5%)
SMA 2001.366 (-29.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)262.91K
Avg Vol (10d)666.08K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—